These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 4794032)

  • 41. [Passive immunization using immunoglobulins].
    Vodĭcková M; Domorázková E
    Zdrav Prac; 1973 Sep; 23(9):523-4. PubMed ID: 4493353
    [No Abstract]   [Full Text] [Related]  

  • 42. Successful treatment of candidiasis with transfer factor.
    Pabst HF; Swanson R
    Br Med J; 1972 May; 2(5811):442-3. PubMed ID: 5031659
    [No Abstract]   [Full Text] [Related]  

  • 43. Letter: Protein replacement therapy for genetic disease.
    Pena SD
    Lancet; 1973 Oct; 2(7834):907. PubMed ID: 4126939
    [No Abstract]   [Full Text] [Related]  

  • 44. Modern practice in immunization. 3. Passive immunization.
    Banker DD
    Indian J Med Sci; 1968 May; 22(5):335-49. PubMed ID: 5678435
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the therapeutic value of purified anti-diphtheria serums].
    SANDOR G; LEMETAYER E; NICOL
    Bull Acad Natl Med; 1949 Feb; 133(7-8):175. PubMed ID: 18118594
    [No Abstract]   [Full Text] [Related]  

  • 46. [Purification of antitoxic serums].
    AMOUREUX G; YEU F
    Ann Inst Pasteur (Paris); 1951 Feb; 80(2):165-74. PubMed ID: 14829892
    [No Abstract]   [Full Text] [Related]  

  • 47. An Examination into the Value of Certain Antiseptics Used for the Preservation of Antitoxic and Other Immune Serums.
    McFarland J
    Public Health Pap Rep; 1902; 28():506-8. PubMed ID: 19601088
    [No Abstract]   [Full Text] [Related]  

  • 48. Antitoxic Serums.
    Houghton EM
    Buffalo Med J; 1898 Jul; 37(12):881-891. PubMed ID: 36887985
    [No Abstract]   [Full Text] [Related]  

  • 49. Factors influencing the maintenance of antitoxic immunity.
    BARR M; GLENNY AT
    Lancet; 1949 Apr; 1(6555):646-9. PubMed ID: 18117303
    [No Abstract]   [Full Text] [Related]  

  • 50. [Transmission mechanism of viral hepatitis and immunity against diphtheria].
    Mureşan J; Răcăşan R; Părău T; Dimoftache E; Szilăgyi B; Munteanu O
    Z Gesamte Hyg; 1967 Dec; 13(12):909-11. PubMed ID: 5590290
    [No Abstract]   [Full Text] [Related]  

  • 51. [The historical significance of passive and active immunization in the therapy of diphtheria].
    Regöly-Mérei G
    Orv Hetil; 1969 Feb; 110(8):432-3. PubMed ID: 5779680
    [No Abstract]   [Full Text] [Related]  

  • 52. [State of antitoxic antidiphtheria immunity in 15- to 17-year-old adolescents].
    Deviatova NI; Khazanov MI; Stupakova TF; Baryshnikova VV; Mironchik VV
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Sep; 50(9):37-42. PubMed ID: 4275084
    [No Abstract]   [Full Text] [Related]  

  • 53. Intramuscular and intravenous ADS treatment. A comparison of efficacy.
    Sudiantoro JE; Sebodo T; Saryanto ; Setiyono ; Saliki ; Ismangoen
    Paediatr Indones; 1986; 26(1-2):1-8. PubMed ID: 3703564
    [No Abstract]   [Full Text] [Related]  

  • 54. [Passive immunity obtained by different routes of administration of purified and unpurified antitoxic serums].
    Devissaguet A; Devissaguet JP; Plissier M
    Ann Pharm Fr; 1973 Apr; 31(4):293-304. PubMed ID: 4794032
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.